794 related articles for article (PubMed ID: 32979314)
41. SARS-CoV-2 Seroprevalence among a Southern U.S. Population Indicates Limited Asymptomatic Spread under Physical Distancing Measures.
Barzin A; Schmitz JL; Rosin S; Sirpal R; Almond M; Robinette C; Wells S; Hudgens M; Olshan A; Deen S; Krejci P; Quackenbush E; Chronowski K; Cornaby C; Goins J; Butler L; Aucoin J; Boyer K; Faulk J; Alston-Johnson D; Page C; Zhou Y; Fiscus L; Damania B; Dittmer DP; Peden DB
mBio; 2020 Sep; 11(5):. PubMed ID: 32994333
[TBL] [Abstract][Full Text] [Related]
42. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
43. Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil.
Barros AJD; Victora CG; Menezes AMB; Horta BL; Barros FC; Hartwig FP; Victora GD; Vidaletti LP; Silveira MF; Mesenburg MA; Jacques N; Struchiner CJ; Brust FR; Dall'Agnol MM; Delamare APL; François CHR; Ikeda MLR; Pellegrini DCP; Reuter CP; Silva SGD; Dellagostin OA; Hallal PC
Rev Saude Publica; 2021; 55():78. PubMed ID: 34816981
[TBL] [Abstract][Full Text] [Related]
44. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Grzelak L; Temmam S; Planchais C; Demeret C; Tondeur L; Huon C; Guivel-Benhassine F; Staropoli I; Chazal M; Dufloo J; Planas D; Buchrieser J; Rajah MM; Robinot R; Porrot F; Albert M; Chen KY; Crescenzo-Chaigne B; Donati F; Anna F; Souque P; Gransagne M; Bellalou J; Nowakowski M; Backovic M; Bouadma L; Le Fevre L; Le Hingrat Q; Descamps D; Pourbaix A; Laouénan C; Ghosn J; Yazdanpanah Y; Besombes C; Jolly N; Pellerin-Fernandes S; Cheny O; Ungeheuer MN; Mellon G; Morel P; Rolland S; Rey FA; Behillil S; Enouf V; Lemaitre A; Créach MA; Petres S; Escriou N; Charneau P; Fontanet A; Hoen B; Bruel T; Eloit M; Mouquet H; Schwartz O; van der Werf S
Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32817357
[TBL] [Abstract][Full Text] [Related]
45. Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample.
Maver Vodičar P; Oštrbenk Valenčak A; Zupan B; Avšič Županc T; Kurdija S; Korva M; Petrovec M; Demšar J; Knap N; Štrumbelj E; Vehovar V; Poljak M
Clin Microbiol Infect; 2020 Nov; 26(11):1514-1519. PubMed ID: 32688068
[TBL] [Abstract][Full Text] [Related]
46. IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea.
Song SK; Lee DH; Nam JH; Kim KT; Do JS; Kang DW; Kim SG; Cho MR
J Korean Med Sci; 2020 Jul; 35(29):e269. PubMed ID: 32715672
[TBL] [Abstract][Full Text] [Related]
47. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
48. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
[TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
[TBL] [Abstract][Full Text] [Related]
50. Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis.
Dawood FS; Ricks P; Njie GJ; Daugherty M; Davis W; Fuller JA; Winstead A; McCarron M; Scott LC; Chen D; Blain AE; Moolenaar R; Li C; Popoola A; Jones C; Anantharam P; Olson N; Marston BJ; Bennett SD
Lancet Infect Dis; 2020 Nov; 20(11):1255-1262. PubMed ID: 32738203
[TBL] [Abstract][Full Text] [Related]
51. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
52. COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study.
Jefferies S; French N; Gilkison C; Graham G; Hope V; Marshall J; McElnay C; McNeill A; Muellner P; Paine S; Prasad N; Scott J; Sherwood J; Yang L; Priest P
Lancet Public Health; 2020 Nov; 5(11):e612-e623. PubMed ID: 33065023
[TBL] [Abstract][Full Text] [Related]
53. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
54. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil.
Rezende LFM; Thome B; Schveitzer MC; Souza-Júnior PRB; Szwarcwald CL
Rev Saude Publica; 2020; 54():50. PubMed ID: 32491091
[TBL] [Abstract][Full Text] [Related]
55. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.
Siegler AJ; Sullivan PS; Sanchez T; Lopman B; Fahimi M; Sailey C; Frankel M; Rothenberg R; Kelley CF; Bradley H
Ann Epidemiol; 2020 Sep; 49():50-60. PubMed ID: 32791199
[TBL] [Abstract][Full Text] [Related]
56. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
[TBL] [Abstract][Full Text] [Related]
57. Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020.
Hallowell BD; Carlson CM; Jacobs JR; Pomeroy M; Steinberg J; Tenforde MW; McDonald E; Foster L; Feldstein LR; Rolfes MA; Haynes A; Abedi GR; Odongo GS; Saruwatari K; Rider EC; Douville G; Bhakta N; Maniatis P; Lindstrom S; Thornburg NJ; Lu X; Whitaker BL; Kamili S; Sakthivel SK; Wang L; Malapati L; Murray JR; Lynch B; Cetron M; Brown C; Roohi S; Rotz L; Borntrager D; Ishii K; Moser K; Rasheed M; Freeman B; Lester S; Corbett KS; Abiona OM; Hutchinson GB; Graham BS; Pesik N; Mahon B; Braden C; Behravesh CB; Stewart R; Knight N; Hall AJ; Killerby ME
Emerg Infect Dis; 2020 Sep; 26(9):1998-2004. PubMed ID: 32620182
[TBL] [Abstract][Full Text] [Related]
58. Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020.
Bogogiannidou Z; Vontas A; Dadouli K; Kyritsi MA; Soteriades S; Nikoulis DJ; Mouchtouri VΑ; Koureas M; Kazakos EI; Spanos EG; Gioula G; Ntzani EE; Eleftheriou AA; Vatopoulos A; Petinaki E; Papaevangelou V; Speletas M; Tsiodras S; Hadjichristodoulou C
Euro Surveill; 2020 Aug; 25(31):. PubMed ID: 32762796
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 and Inequity: a Comparative Spatial Analysis of New York City and Chicago Hot Spots.
Maroko AR; Nash D; Pavilonis BT
J Urban Health; 2020 Aug; 97(4):461-470. PubMed ID: 32691212
[TBL] [Abstract][Full Text] [Related]
60. Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020.
Menachemi N; Yiannoutsos CT; Dixon BE; Duszynski TJ; Fadel WF; Wools-Kaloustian KK; Unruh Needleman N; Box K; Caine V; Norwood C; Weaver L; Halverson PK
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):960-964. PubMed ID: 32701938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
